Home / Business and Economy / Robotic Surgery Rivalry Intensifies as Intuitive Surgical Confronts New Competitors
Robotic Surgery Rivalry Intensifies as Intuitive Surgical Confronts New Competitors
12 Nov
Summary
- Intuitive Surgical faces growing competition in robotic-assisted surgery market
- Cathie Wood's Ark Invest and billionaire Izzy Englander's Millennium Management own Intuitive Surgical shares
- Intuitive Surgical's valuation is high at 48x forward earnings, above healthcare sector average
As of November 12th, 2025, Intuitive Surgical, a leading medical device company specializing in robotic-assisted surgery (RAS) systems, is facing a growing competitive landscape. The company's flagship da Vinci system, which has dominated the market for over two decades, is now set to compete with Medtronic's Hugo system and potentially Johnson & Johnson's Ottava system in the coming years.
Medtronic's Hugo system has already demonstrated strong clinical trial performance and is awaiting U.S. regulatory clearance, which is likely to be granted. This will allow Medtronic to expand the Hugo system into urologic procedures, where the da Vinci system has been the primary player. Additionally, Medtronic is expected to seek label expansions for the Hugo system across other indications where the da Vinci system is currently approved.
